Biodesix

“By outsourcing our billing to Quadax, we were able to focus on our clinical mission—helping providers offer a personalized approach to cancer care for patients facing lung cancer.”

For its lab tests, Biodesix found that payers often required validation in the form of prior authorization, medical records and more—but often after the claim had been submitted. They sought a better way. 

Biodesix partnered with Quadax and working collaboratively, developed a custom database specific to Biodesix, utilizing payer information from over 800 payers and designing workflows specific to their needs. The result? Fewer denials and greater efficiency. 

Larger Payments for Labs Producing Faster COVID-19 Results

CMS incentivizes labs to complete high throughput COVID-19 tests quicker

The Centers for Medicare and Medicaid Services (CMS) recently announced starting January 1, 2021, Medicare will pay $100 to laboratories that complete high throughput COVID-19 diagnostic tests within two calendar days of the specimen being collected. Also effective January 1, 2021, for laboratories that take longer than two days to complete these tests, Medicare will pay $75.